Covington & Burling advised AbbVie on the transaction, and Fenwick & West advised Aliada Therapeutics. AbbVie (NYSE: ABBV), a pharmaceutical firm, announced it has entered into...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Treehouse on the transaction. Treehouse announced $16.6 million in Series A funding. Lead investor Flourish Ventures, Eaton, Veriten, MassMutual Ventures,...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Socure on the transaction. Socure, the leading provider of artificial intelligence for digital identity verification, fraud prevention, and sanction screening,...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented AvenCell Therapeutics in the transaction, and Wilson Sonsini Goodrich & Rosati advised Novo Holdings and F-Prime Capital on the transaction. AvenCell Therapeutics...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised General Atlantic on patent matters related to the transaction. Seaport Therapeutics (Seaport), a clinical-stage biopharmaceutical company that is advancing novel...
You must be a Standard 1 Year member to access this content.
Sidley Austin represented Ocuphire Pharma, Inc. in the transaction, and Smith, Anderson, Blount, Dorsett, Mitchell & Jernigan represented Opus Genetics Inc. Wilson Sonsini Goodrich & Rosati...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Stripe on the transaction. Financial infrastructure platform Stripe confirmed that it is acquiring stablecoin infrastructure provider Bridge. The transaction, which...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Goldman Sachs Alternatives on patent matters related to the transaction. Triveni Bio, a biotech company, announced the completion of a...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Terray on the transaction. Terray Therapeutics (Terray), a biotechnology company, announced raising $120 million in Series B funding round. The...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Kairos Power in the transaction. Kairos Power and Google announced they have signed a Master Plant Development Agreement, creating a...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Clearway Energy Group on the transaction. Clearway Energy Group (Clearway) announced that it has closed financing and begun construction on...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Movet on the transaction. Colombia-based Movet, a veterinary network, announced that it completed a $5 million Series A financing round...
You must be a Standard 1 Year member to access this content.
